Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01585194Phase 2Completed
Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
Metastatic Uveal MelanomaStage IV Uveal Melanoma AJCC v7
PrincipalinvestigatorStart date: 2012-11-29
NCT01413191Phase 2Completed
Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+3 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael McNamara, MD

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Related
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Jeffrey Weber

University of Southern California

Related
4 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeIris MelanomaCiliary Body and Choroid Melanoma, Small Size+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Takami Sato, MD

Thomas Jefferson University

Related
2 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma
Similarity Score11%

Naomi Balzer-Haas

Princess Margaret Hospital Phase 2 Consortium

Related
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeIris MelanomaRecurrent Intraocular Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Gary Croghan

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeIris MelanomaRecurrent Intraocular Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Alexander N Shoushtari

Memorial Sloan Kettering Cancer Center

Related
2 trials

Shared therapeutic areas:

Stage IV Uveal Melanoma AJCC v7Metastatic Uveal Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

David H Lawson

Eastern Cooperative Oncology Group

Related
1 trials

Shared therapeutic areas:

Iris MelanomaStage IV Uveal Melanoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Lars Ny

Department of Oncology, Sahlgrenska University Hospital, Sweden

Related
1 trials

Shared therapeutic areas:

Metastatic Uveal Melanoma
Similarity Score4%

Sylvie DOLBEAULT, PHD

Institut Curie

Related
1 trials

Shared therapeutic areas:

Metastatic Uveal Melanoma
Similarity Score4%

Lauren Banks, MD, PhD

Memorial Sloan Kettering Cancer Center

Related
1 trials

Shared therapeutic areas:

Metastatic Uveal Melanoma
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01585194Phase 2PrincipalInvestigator

Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

Metastatic Uveal MelanomaStage IV Uveal Melanoma AJCC v7
Completed
NCT01413191Phase 2PrincipalInvestigator

Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye

Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+3 more
Completed

All 2 trials loaded